{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:26:26Z","timestamp":1790519186457,"version":"4.1.0"},"reference-count":88,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:00:00Z","timestamp":1539648000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02390","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T06:11:52Z","timestamp":1539670312000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":49,"title":["Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis"],"prefix":"10.3389","volume":"9","author":[{"given":"Nicoletta","family":"Del Papa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Pignataro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Zaccara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanda","family":"Maglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonina","family":"Minniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,10,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/bjd.15993","article-title":"Efficacy and safety of autologous haematopoietic stem cell transplantation in systemic sclerosis: a systematic review of the literature","volume":"178","author":"Eyraud","year":"2018","journal-title":"Br J Dermatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","article-title":"Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial","volume":"378","author":"Burt","year":"2011","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial","volume":"311","author":"van","year":"2014","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1703327","article-title":"Myeloablative autologous stem-cell transplantation for severe scleroderma","volume":"378","author":"Sullivan","year":"2018","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1182\/bloodadvances.2017010041","article-title":"Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases","volume":"1","author":"Snowden","year":"2017","journal-title":"Blood Adv"},{"key":"B6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1182\/blood-2015-11-678607","article-title":"Rebooting autoimmunity with autologous HSCT","volume":"127","author":"Snowden","year":"2016","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1093\/rheumatology\/keu285","article-title":"Old medications and new targeted therapies in systemic sclerosis","volume":"54","author":"Nagaraja","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41584-018-0021-9","article-title":"Existing and novel biomarkers for precision medicine in systemic sclerosis","volume":"14","author":"Wermuth","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.autrev.2014.08.029","article-title":"Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature","volume":"13","author":"Ferri","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1007\/s00296-017-3826-y","article-title":"Determinants of mortality in systemic sclerosis: a focused review","volume":"38","author":"Poudel","year":"2017","journal-title":"Rheumatol Int"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Kowal-Bielecka","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1002\/art.22204","article-title":"A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma","volume":"54","author":"Hoyles","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B15","first-page":"1064","article-title":"Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label study","volume":"35","author":"B\u00e9rezn\u00e9","year":"2008","journal-title":"J Rheumatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1164\/rccm.200702-326OC","article-title":"Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease","volume":"176","author":"Tashkin","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"234","DOI":"10.5301\/jsrd.5000205","article-title":"Mycophenolate mofetil following cyclophosphamide in worsening systemic sclerosis-associated interstitial lung disease","volume":"1","author":"Launay","year":"2016","journal-title":"J scleroderma relat disord"},{"key":"B20","doi-asserted-by":"publisher","first-page":"R124","DOI":"10.1186\/ar2534","article-title":"Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies. Arthritis Res Ther","volume":"10","author":"Nannini","year":"2008"},{"key":"B21","first-page":"RA187","article-title":"The efficacy of treatment for systemic sclerosis interstitial lung disease: results from a meta-analysis","volume":"16","author":"Broad","year":"2010","journal-title":"Med Sci Monit"},{"key":"B22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/BOR.0000000000000172","article-title":"Systemic sclerosis: a systematic review on therapeutic management from 2011 to 2014","volume":"27","author":"Young","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1001\/jama.299.8.925","article-title":"Clinical applications of blood-derived and marrow-derived stem cells for non malignant diseases","volume":"299","author":"Burt","year":"2008","journal-title":"JAMA"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1200\/JCO.2005.05.158","article-title":"Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma","volume":"23","author":"Brown","year":"2005","journal-title":"J Clin Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1200\/JCO.2003.07.113","article-title":"Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients","volume":"21","author":"Armitage","year":"2003","journal-title":"J Clin Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.bmt.1703081","article-title":"Collection of hematopoietic stem cells from patients with autoimmune diseases","volume":"28","author":"Burt","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"B27","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1212\/WNL.54.11.2147","article-title":"Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor","volume":"54","author":"Openshaw","year":"2000","journal-title":"Neurology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/sj.bmt.1701486","article-title":"A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilization in patients with severe active rheumatoid arthritis","volume":"22","author":"Snowden","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"B29","first-page":"839","article-title":"Mobilization and selection of peripheral blood hematopoietic progenitors in children with systemic sclerosis","volume":"84","author":"Locatelli","year":"1999","journal-title":"Haematologica"},{"key":"B30","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1002\/art.1780401017","article-title":"A phase 1 study to address the safety and efficacy of granulocyte colony-stimulating factor for the mobilization of hematopoietic progenitor cells in active rheumatoid arthritis","volume":"40","author":"McGonagle","year":"1997","journal-title":"Arthritis Rheum"},{"key":"B31","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/sj.bmt.1704656","article-title":"Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis","volume":"34","author":"Saccardi","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"B32","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/ard.2003.011205","article-title":"Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT\/EULAR Registry","volume":"63","author":"Farge","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/S0140-6736(12)62114-X","article-title":"Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis","volume":"381","author":"Burt","year":"2013","journal-title":"Lancet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/sj.bmt.1705579","article-title":"Mobilization, harvesting and selection of peripheral blood stem cells in patients with autoimmune diseases undergoing autologous hematopoietic stem cell transplantation","volume":"39","author":"Statkute","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"B35","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/ejh.12686","article-title":"Low-dose cyclophosphamide effectively mobilizes peripheral blood stem cells in patients with autoimmune disease","volume":"97","author":"Blank","year":"2016","journal-title":"Eur J Haematol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/bmt.2015.299","article-title":"Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?","volume":"51","author":"Oliveira","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"B37","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/08916930802197081","article-title":"Immune re-education following autologous hematopoietic stem cell transplantation","volume":"41","author":"Abrahamsson","year":"2008","journal-title":"Autoimmunity"},{"key":"B38","doi-asserted-by":"publisher","first-page":"5233","DOI":"10.1182\/blood-2007-12-128488","article-title":"Autologous bone marrow transplantation in autoimmune arthritis restores immune homeostasis through CD4+CD25+Foxp3+ regulatory T cells","volume":"111","author":"Roord","year":"2008","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1182\/blood-2008-07-168286","article-title":"Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system","volume":"113","author":"Alexander","year":"2009","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1182\/blood-2005-06-2269","article-title":"Apoptosis and complement-mediated lysis of myeloma cells by polyclonal rabbit antithymocyte globulin","volume":"107","author":"Zand","year":"2006","journal-title":"Blood"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1002\/art.21036","article-title":"Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis","volume":"52","author":"Farge","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B42","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1182\/bloodadvances.2017011072.","article-title":"Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients","volume":"2","author":"Arruda","year":"2018","journal-title":"Blood Adv"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-018-0162-0","article-title":"Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis","author":"Arruda","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"B44","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jaut.2011.02.009","article-title":"Programmed death-1 is required for systemic self-tolerance in newly generated T cells during the establishment of immune homeostasis","volume":"36","author":"Thangavelu","year":"2011","journal-title":"J Autoimmun."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3560","DOI":"10.1002\/eji.201444688","article-title":"PD-1 is not required for natural or peripherally induced regulatory T cells: Severe autoimmunity despite normal production of regulatory T cells","volume":"44","author":"Ellestad","year":"2014","journal-title":"Eur J Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-016-0388-5","article-title":"Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients","author":"Farge","year":"2017","journal-title":"J Hematol Oncol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/bmt.2009.139","article-title":"T-cell clones persisting in the circulation after autologous hematopoietic SCT are undetectable in the peripheral CD34+ selected graft","volume":"45","author":"Dubinsky","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"B48","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1093\/rheumatology\/keq414","article-title":"Analysis of immune reconstitution after autologous CD34+ stem\/progenitor cell transplantation for systemic sclerosis: predominant reconstitution of Th1 CD4+ T cells","volume":"50","author":"Tsukamoto","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"B49","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/rheumatology\/kew319","article-title":"Analysis of anti-topoisomerase I antibodies in patients with systemic sclerosis before and after autologous stem cell transplantation","volume":"56","author":"Henes","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"B50","article-title":"Molecular recognition patterns of anti-topoisomerase I-antibodies in patients with systemic sclerosis before and after autologous stem cell transplantation","author":"Glaeser","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1186\/ar2821","article-title":"Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations","author":"Gourh","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"B52","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.autrev.2010.08.003","article-title":"Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis","volume":"10","author":"Baraut","year":"2010","journal-title":"Autoimmun Rev"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/bmt.2016.77","article-title":"Evolution of serum cytokine profile after hematopoietic stem cell transplantation in systemic sclerosis patients","volume":"51","author":"Michel","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"B54","article-title":"Immunoablation followed by autologous stem cell transplantation in systemic sclerosis patients decreases significantly the interferon signature [abstract]","author":"Assassi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1136\/ard.2009.127621","article-title":"Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma","volume":"70","author":"Domsic","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B56","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/acr.22121","article-title":"Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry","volume":"66","author":"Chung","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B57","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/ard.60.6.577","article-title":"Phase I\/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease","volume":"60","author":"Binks","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"B58","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/ard.2007.071464","article-title":"Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis","volume":"67","author":"Vonk","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"B59","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3324\/haematol.2009.013458","article-title":"Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases","volume":"95","author":"Farge","year":"2010","journal-title":"Haematologica"},{"key":"B60","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/bmt.2016.211","article-title":"Autologous hematopoietic stem cell transplantation has better outcomes than conventional therapies in patients with rapidly progressive systemic sclerosis","volume":"52","author":"Del","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.3899\/jrheum.081212","article-title":"Autologous hematopoietic stem cell transplant in systemic sclerosis: quantitative high resolution computed tomography of the chest scoring","volume":"36","author":"Launay","year":"2009","journal-title":"J Rheumatol"},{"key":"B62","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/ard.62.9.901","article-title":"European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria","volume":"62","author":"Valentini","year":"2003","journal-title":"Ann Rheum Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.amjmed.2004.04.031","article-title":"Mortality in systemic sclerosis: an international meta-analysis of individual patient data","volume":"118","author":"Ioannidis","year":"2005","journal-title":"Am J Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/pr.2011.57","article-title":"Complications of autologous hematopoietic stem cell transplantation for patients with autoimmune diseases","volume":"71","author":"Daikeler","year":"2012","journal-title":"Pediatr Res"},{"key":"B65","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.clim.2004.07.006","article-title":"Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases)","volume":"113","author":"Storek","year":"2004","journal-title":"Clin Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"665","DOI":"10.6002\/ect.2015.0336","article-title":"A preliminary online study on menstruation recovery in women after autologous hematopoietic stem cell transplant for autoimmune diseases","volume":"14","author":"Maciejewska","year":"2016","journal-title":"Exp Clin Transplant"},{"key":"B67","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/bmt.2014.248","article-title":"Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: a retrospective study of the EBMT autoimmune diseases working party (ADWP)","volume":"50","author":"Snarski","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"B68","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/bmt.2014.325","article-title":"Secondary malignancies following high dose therapy and autologous hematopoietic cell transplantation-systematic review and meta-analysis","volume":"50","author":"Vaxman","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"B69","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/rheumatology\/kes303","article-title":"Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies","volume":"52","author":"Bonifazi","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1002\/art.37969","article-title":"Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies","volume":"65","author":"Onishi","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B71","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.canep.2013.04.014","article-title":"The risk of cancer development in systemic sclerosis: a meta-analysis","volume":"37","author":"Zhang","year":"2013","journal-title":"Cancer Epidemiol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.beha.2006.09.008","article-title":"Autoimmunity following haematopoietic stem-cell transplantation","volume":"20","author":"Daikeler","year":"2007","journal-title":"Best Pract Res Clin Haematol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1182\/blood-2011-02-336156","article-title":"Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party","volume":"118","author":"Daikeler","year":"2011","journal-title":"Blood"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1182\/blood-2007-02-072389","article-title":"High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study","volume":"110","author":"Nash","year":"2007","journal-title":"Blood"},{"key":"B75","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3899\/jrheum.110868","article-title":"Optimization of autologous stem cell transplantation for systemic sclerosis \u2013 a single-center longterm experience in 26 patients with severe organ manifestations","volume":"39","author":"Henes","year":"2012","journal-title":"J Rheumatol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/sj.bmt.1704763","article-title":"Cardiac toxicity of high-dose chemotherapy","volume":"35","author":"Morandi","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1001\/jama.2012.12347","article-title":"Pulmonary hypertension","volume":"308","author":"Shah","year":"2012","journal-title":"JAMA"},{"key":"B78","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3978\/j.issn.2223-3652.2014.03.06","article-title":"Tools for cardiovascular magnetic resonance imaging","volume":"4","author":"Krishnamurthy","year":"2014","journal-title":"Cardiovasc Diagn Ther"},{"key":"B79","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.semarthrit.2017.03.020","article-title":"Cardiovascular magnetic resonance in systemic sclerosis: \u201cPearls and pitfalls\u201d","volume":"47","author":"Mavrogeni","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/bmt.2017.56","article-title":"Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners","volume":"52","author":"Farge","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"B81","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/bmt.2010.113","article-title":"The impact of smoking on outcomes among patients undergoing hematopoietic SCT for the treatment of acute leukemia","volume":"46","author":"Ehlers","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"B82","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1034\/j.1399-6576.2002.460806.x","article-title":"Immune response in asymptomatic smokers","volume":"46","author":"Zeidel","year":"2002","journal-title":"Acta Anaesthesiol Scand"},{"key":"B83","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/art.1780280706","article-title":"Pulmonary involvement in systemic sclerosis (scleroderma)","volume":"28","author":"Steen","year":"1985","journal-title":"Arthritis Rheum"},{"key":"B84","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s00296-008-0824-0","article-title":"Patterns of pulmonary function in smoking and nonsmoking patients with progressive systemic sclerosis","volume":"29","author":"Quadrelli","year":"2009","journal-title":"Rheumatol Int"},{"key":"B85","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/art.30071","article-title":"Canadian Scleroderma Research Group. Cigarette smoking in patients with systemic sclerosis","volume":"63","author":"Hudson","year":"2011","journal-title":"Arthritis Rheum."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1136\/annrheumdis-2014-205226","article-title":"Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database","volume":"74","author":"Maurer","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B87","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1002\/1529-0131(200112)44:12<2828::AID-ART470>3.0.CO;2-U","article-title":"Improvement in skin thickening in systemic sclerosis associated with improved survival","volume":"44","author":"Steen","year":"2001","journal-title":"Arthritis Rheum."},{"key":"B88","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1136\/annrheumdis-2016-209768","article-title":"The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index","volume":"76","author":"Valentini","year":"2017","journal-title":"Ann Rheum Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02390\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T06:11:56Z","timestamp":1539670316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02390\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,16]]},"references-count":88,"alternative-id":["10.3389\/fimmu.2018.02390"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02390","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,16]]},"article-number":"2390"}}